| pubmed-article:21241463 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21241463 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21241463 | lifeskim:mentions | umls-concept:C0345904 | lld:lifeskim |
| pubmed-article:21241463 | lifeskim:mentions | umls-concept:C0677874 | lld:lifeskim |
| pubmed-article:21241463 | lifeskim:mentions | umls-concept:C1516119 | lld:lifeskim |
| pubmed-article:21241463 | lifeskim:mentions | umls-concept:C0085973 | lld:lifeskim |
| pubmed-article:21241463 | lifeskim:mentions | umls-concept:C0007320 | lld:lifeskim |
| pubmed-article:21241463 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:21241463 | pubmed:dateCreated | 2011-2-10 | lld:pubmed |
| pubmed-article:21241463 | pubmed:abstractText | Hepatocellular carcinoma (HCC) is the fifth most common neoplasia in the world. In the past, treatment of advanced HCC with conventional antineoplastic drugs did not result in satisfactory outcomes: recently, in this patient population the oral multikinase inhibitor sorafenib has been able to induce a statistically significant improvement of overall survival. Similarly to other anti-angiogenic drugs employed in other tumour types, also sorafenib seldom induces the dimensional tumour shrinking usually observed with conventional cytotoxic drugs: data gathered from studies carried out with sorafenib and other competitors under development do not report any complete response in HCV-induced HCC. | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21241463 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21241463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21241463 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21241463 | pubmed:issn | 1471-230X | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:GiannelliGian... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:BresciGiampao... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:BartolozziCar... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:RomanoAntonio... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:AltomareEmanu... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:BertoniMichel... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:BargelliniIre... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:SaccoRodolfoR | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:CapriaAlfonso... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:BattagliaVale... | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:BertiniMarcoM | lld:pubmed |
| pubmed-article:21241463 | pubmed:author | pubmed-author:BozziElenaE | lld:pubmed |
| pubmed-article:21241463 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21241463 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:21241463 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21241463 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21241463 | pubmed:pagination | 4 | lld:pubmed |
| pubmed-article:21241463 | pubmed:dateRevised | 2011-7-25 | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:meshHeading | pubmed-meshheading:21241463... | lld:pubmed |
| pubmed-article:21241463 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21241463 | pubmed:articleTitle | Complete response for advanced liver cancer during sorafenib therapy: case report. | lld:pubmed |
| pubmed-article:21241463 | pubmed:affiliation | Gastroenterology Department, Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy. saccorodolfo@hotmail.com | lld:pubmed |
| pubmed-article:21241463 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21241463 | pubmed:publicationType | Case Reports | lld:pubmed |
